Organs at Risk in Re-Irradiation of Head and Neck Cancer: An Individual Risk-Benefit Tradeoff

被引：0
|
作者：
Held, T. [1 ]
Harrabi, S. B. [1 ]
Lang, K. [1 ]
Akbaba, S. [1 ]
Windisch, P. [2 ]
Bernhardt, D. [1 ]
Rieken, S. [1 ]
Herfarth, K. [1 ]
Debus, J. [1 ]
Adeberg, S. [1 ]
机构：
[1] Heidelberg Univ Hosp, Dept Radiat Oncol, Heidelberg, Germany
[2] Univ Hosp Zurich, Dept Radiat Oncol, Zurich, Switzerland
来源：
RADIOTHERAPY AND ONCOLOGY | 2020年 / 152卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PO-0816
引用
收藏
页码：S442 / S442
页数：1
相关论文
共 50 条
  • [21] Re-irradiation with concurrent chemotherapy for recurrent head and neck cancer
    Roman, E.
    Raez, L.
    Biagioli, M.
    Harvey, M.
    Blaya, M.
    Tolba, K.
    Bathia, R.
    Markoe, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 294S - 294S
  • [22] Volume dose to Organs at risk during the irradiation of Head and neck cancer in Tomotherapy
    Wilhelm-Buchstab, T.
    Garbe, S.
    Simon, B.
    Luetter, C.
    Muedder, T.
    Schoroth, F.
    Schild, H. H.
    Leitzen, C.
    Schueller, H.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2011, 187 : 26 - 27
  • [23] A review on re-irradiation for recurrent and second primary head and neck cancer
    Kasperts, N
    Slotman, B
    Leemans, CR
    Langendijk, JA
    ORAL ONCOLOGY, 2005, 41 (03) : 225 - 243
  • [24] Re-irradiation with concurrent Nivolumab in locally recurrent Head and Neck Cancer
    von der Grun, J.
    Altay-Langguth, A.
    Balermpas, P.
    Brandts, C.
    Balster, S.
    Ghanaati, S.
    Winkelmann, R.
    Burck, I.
    Rodel, F.
    Martin, D.
    Rodel, C.
    RADIOTHERAPY AND ONCOLOGY, 2021, 161 : S855 - S855
  • [25] Clinical evidence after brachytherapy re-irradiation - head and neck cancer
    Kanikowski, M.
    Skowronek, J.
    RADIOTHERAPY AND ONCOLOGY, 2015, 115 : S164 - S165
  • [26] Concurrent chemotherapy and re-irradiation for locoregionally recurrent head and neck cancer
    Salama, Joseph K.
    Vokes, Everett E.
    SEMINARS IN ONCOLOGY, 2008, 35 (03) : 251 - 261
  • [27] Re-irradiation of head and neck cancer - Impact of total dose on outcome
    Janssen, S.
    Bremer, M.
    Stieve, M.
    Eckardt, A.
    Karstens, J.
    Meyer, A.
    ONKOLOGIE, 2010, 33 : 125 - 125
  • [28] Risk-benefit information at the individual level
    不详
    HEALTH AFFAIRS, 2007, 26 (03) : 715 - 715
  • [29] Risk of Severe Laryngeal Toxicity Following Re-Irradiation With Head and Neck Stereotactic Body Radiation Therapy
    Gebhardt, B. J.
    Vargo, J. A.
    Ling, D. C.
    Jones, B.
    Clump, D. A., II
    Ohr, J.
    Ferris, R. L.
    Heron, D. E.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2018, 100 (05): : 1368 - 1368
  • [30] Re-irradiation of head and neck tumors - Benefits and toxicities
    Eisbruch, A
    Dawson, L
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 1999, 13 (04) : 825 - +
12345